Teva Pharmaceutical Industries Ltd.

Teva Pharmaceutical Industries Ltd.

Teva Pharmaceutical Industries Ltd.

Date Founded



5 Basel Street,Petach Tikva, HaMerkaz 4951033

Type of Company


Employees (Worldwide)



Hospitals & Patient Services
Wholesale: Consumer Non-Durables/Sundries
Other Business & Consulting Services
Medical Support Services
Internet Software & Services

Company Description

Teva is a global generic pharmaceuticals leader and one of the top 15 pharmaceutical companies in the world. Headquartered in Israel, Teva operates in 60 countries and has 46,000 employees worldwide. Established in 1901, Teva takes great pride in its long tradition of leadership and dedication to excellence

Contact Data
Trying to get in touch with decision makers at Teva Pharmaceutical Industries Ltd.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

President & Chief Executive Officer

Director & President & Chief Executive Officer

Executive Vice President & Chief Financial Officer

Chief Internal Auditor

Executive Vice President, Chief Legal Officer

General Manager, Products

Senior Director, Investor Relations

Executive Vice President, Global Operations

Executive Vice President, North America Commercial

Group Executive Vice President, Chief Legal Officer & Company Secretary

Board of Directors

Founder at Centrexion Therapeutics Corp.

Founder at Bridger Management LLC

Managing General Partner & Co-Founder at Pitango Venture Capital

Former Chief Executive Officer & Director at OraPharma, Inc.

Director & President & Chief Executive Officer at Teva Pharmaceutical Industries Ltd.

Director at Forest Laboratories LLC

Director-Discovery & Innovation at HMH Hospitals Corp., Inc.

Chairman of the Board of Governors at Jerusalem College of Engineering

Former President & General Manager of Emerging Markets at Pfizer, Inc.

Executive Partner, Private Equity at Sofinnova Investments, Inc.

Paths to Teva Pharmaceutical Industries Ltd.
Potential Connections via
Relationship Science
Teva Pharmaceutical Industries Ltd.
Owners & Shareholders
Details Hidden

Abrams Capital aims to maximize long-term total returns in variable market and economic conditions, while emphasizing preservation of capital. Their investment strategy is opportunistic and follows a fundamental, value-oriented approach. Investments generally are made with a long-term time horizon and are generally unlevered and long-biased. Abrams Capital and their affiliates have acquired and liquidated investments across a wide spectrum of asset types, investment strategies, market sectors, market cycles and industries. This spectrum includes, but is not limited to, domestic and foreign equity and debt securities, distressed securities, and private and/or illiquid investments.

Details Hidden

Excellence Investments’ activities are divided in to: Investment Management, which includes investment management and marketing services in the field of securities and financial instruments such as management of mutual funds and real estate investment trusts (REIT) management; Issuance of structured products, which includes issuance and trade of structured exchange traded bonds and issuance of non traded structured products; Issuance of financial instruments, which includes issuance and trade of deposit certificates and issuance and trade of ETFs and deposits; Investment banking and underwriting; Stock Exchange and Trading Services, which includes stock exchange members and brokerage service, primarily to institutional investors, as well as Provident funds and pension funds.

Details Hidden

MIC-IP is an active manager which creates personally tailored solutions for client needs at all stages of life.

Recent Transactions
Details Hidden

American Well Corp. issued USD Common Stock

Details Hidden

Catalent, Inc. purchases Teva Takeda Pharma Ltd. /Minakuchi Packaging Facility from Teva Pharmaceutical Industries Ltd.

Details Hidden

Ohara Pharmaceutical Co., Ltd. purchases Teva Takeda Yakuhin Ltd. /Koka Factory from Teva Pharmaceutical Industries Ltd.

Transaction Clients

Advised on American Well Corp. issued USD Common Stock

Transaction Advisors
Legal Advisor

Advised onTeva Pharmaceutical Industries Ltd. purchases Barr Pharmaceuticals, Inc.

Investment Advisor

Advised onTeva Pharmaceutical Industries Ltd. purchases Barr Pharmaceuticals, Inc.

Legal Advisor

Advised onTeva Pharmaceutical Industries Ltd. purchases Cephalon, Inc.

Legal Advisor

Advised onTeva Pharmaceutical Industries Ltd. purchases Barr Pharmaceuticals, Inc.

Legal Advisor

Advised onTeva Pharmaceutical Industries Ltd. purchases Cephalon, Inc.

Legal Advisor

Advised onTeva Pharmaceutical Industries Ltd. purchases Barr Pharmaceuticals, Inc.

Advisors & Consultants
Legal Advisor

Global Head of Intellectual Property & General Counsel for US at Hikma Pharmaceuticals Plc

Legal Advisor

Partner at Kirkland & Ellis LLP

Legal Advisor

Partner, Chicago Co-Chair, Litigation Department at Winston & Strawn LLP


H. Lundbeck A/S engages in the research, development, and market of pharmaceutical products for the treatment of psychiatric and neurological disorders. It operates through the following geographical segments: Europe, the Unites States of America, and International Markets. Its product portfolio targets the following diseases: Alzheimer's, depression, Parkinson's, Schizophrenia, alcohol dependence, anxiety, bipolar disorder, epilepsy, and Huntington's. The company was founded by Hans Lundbeck on August 14, 1915 and is headquartered in Valby, Denmark.

AmerisourceBergen Corp. engages provision of pharmaceutical products and business solutions that improve access to care. It operates through the Pharmaceutical Distribution Services and Other segments. The Pharmaceutical Distribution Services segment distributes a comprehensive offering of brand-name, specialty brand-name & generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies & equipment, outsourced compounded sterile preparations, and related services to a wide variety of healthcare providers, including acute care hospitals and health systems, independent & chain retail pharmacies, mail order pharmacies, medical clinics, long-term care & alternate site pharmacies, and other customers. The Other segment focuses on global commercialization services and animal health and includes ABCS, World Courier, and MWI. The company is headquartered in Chesterbrook, PA.

McKesson is dedicated to delivering the vital medicines, medical supplies and information technologies that enable the health care industry to provide patients better, safer care. McKesson is made up of many businesses, all serving the health care industry. Our businesses fall into one of two primary categories: Distribution solutions. We are the largest pharmaceutical distributor in North America, distributing one-third of the medicines used every day. As one of the leading pharmaceutical companies, we supply more than 40,000 U.S. pharmacy locations, from Wal-Mart to the Department of Veterans Affairs to community pharmacies and hospitals. McKesson is also one of the leading medical supply companies and distributes medical-surgical supplies and homecare supplies. Healthcare Technology solutions. We develop and install healthcare information technology systems that eliminate the need for paper prescriptions and paper medical records. Our software and hardware are used in more than 70% of the nation's hospitals with more than 200 beds. Our hospital information system solutions include electronic health record system (EHR) and clinical decision support system such as Interqual. McKesson's Healthcare IT division also serves diverse areas within the health industry by offering solutions such as pharmacy automation and medical claims management software. McKesson publicly traded on NYSE under MCK Businesses Serving our customers—pharmacies, medical and pharmaceutical manufacturers, hospitals, and insurers—as the health care industry evolves is our primary goal. We have business lines to automate processes from medical supplies packaging to claims management, and revenue cycle management to medical imaging. McKesson's long history in pharmaceutical industry History McKesson has a long history in health care. We’ve been a trusted provider of medical supplies and goods for more than 175 years.

Key Stats and Financials As of 2020
Market Capitalization
Total Enterprise Value
Earnings Per Share
Enterprise Value / Sales
TEVNet Income
Debt TEV
Enterprise Value EBITDAOperating
Three Year Compounded Annual Growth Rate Of Revenue
Total Equity
Total Debt
Net Profit
Non-Profit Donations & Grants
Details Hidden

Microchips Biotech, Inc. develops drug delivery systems and bio sensing devices. Its technologies are designed to transform electromechanical medical devices into highly tuned biochemical sensing and therapy systems. The company was founded by Terrance G. McGuire, Michael J. Cima, John T. Santini, Jr. and Robert S. Langer, Jr. in 1999 and is headquartered in Lexington, MA.

Details Hidden

Proneuron Biotechnologies, Inc. develops therapies for nervous disorders. The company develops therapies for neurological, ophthalmologic and immune-related disorders such as spinal cord injuries, multiple sclerosis, glaucoma, Parkinson's disease and Alzheimer's diseases. It was founded in 1996 and is headquartered in New York, NY.

Details Hidden

VESSL Therapeutics Ltd. develops cell-based therapies for large patient populations. Its solutions include MultiGeneAngio fo Peripheral Artery Disease and MultiGeneGraft for end-stage renal disease. The company was founded in August 2000 by Moshe Y. Flugelman and Basil S. Lewis and is headquartered in Haifa, Israel.

Details Hidden

Co-Founder at Oak HC/FT Management Co. LLC

Details Hidden

Chief Executive Officer & Director at Astarte Medical Partners, Inc.

Details Hidden

Founder at DalCor Pharmaceuticals Canada, Inc.

Antares Pharma, Inc. Medical Products & Equipment | Ewing, NJ

Antares Pharma is a revenue-generating product focused specialty pharmaceutical company that has developed three proprietary platforms, two of which now include FDA approved products. Our products typically improve safety and efficacy profiles by minimizing dosing and reducing side effects while improving patient compliance. We focus on self-injection pharmaceutical products and technologies and topical gel -based products. Our subcutaneous injection technology platforms include Vibex™ disposable pressure-assisted auto injectors, Vision® reusable needle-free injectors, and disposable multi-use pen injectors.

Codexis, Inc. Chemicals | Redwood City, CA

Codexis, Inc. is an enzyme engineering company, which engages in the development and sale of therapeutics. It operates through the Performance Enzymes and Novel Biotherapeutics segments. The Performance Enzymes segment commercializes CodeEvolver protein engineering technology platform and products in the pharmaceuticals market. The Novel Biotherapeutics segment targets new opportunities to discover and improve biotherapeutic drug candidates. Its products include screening kits and Codex HiFi Hot Start DNA Polymerase. The company was founded in January 2002 and is headquartered in Redwood City, CA.

Enzymotec Ltd. Biotechnology | Migdal Haemeq, Israel

Enzymotec Ltd. develops and manufactures bio functional ingredients for health needs. The company was founded on March 8, 1998 and is headquartered in Migdal HaEmeq, Israel.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Teva Pharmaceutical Industries Ltd.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Teva Pharmaceutical Industries Ltd.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Teva Pharmaceutical Industries Ltd..